It has the reactor, biotechs and the hospitals to do that last two, and even has a growing pool of expertise to run these. What it doesn’t have, yet, is many advanced manufacturers to do the first critical parts such as sifting through old mine tailings for precursor materials and making nuclear isotopes for industry use, such as clinical trials.
Episode 4 of NUKED features entX’s Managing Director, Bryn Jones and Cyclowest Head of Production Dr Jacquie Cawthray about whether Australia has the ‘it’ factor to go it alone.
Listen to more from Phase III.
